Cargando…
Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development
The central nervous system (CNS) has, among all organ systems in the human body, the highest failure rate of traditional small-molecule drug development, ranging from 80–100% depending on the area of disease research. This has led to widespread abandonment by the pharmaceutical industry of research...
Autores principales: | Bose, Meenakshi, Farias Quipildor, Gabriela, Ehrlich, Michelle E., Salton, Stephen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688574/ https://www.ncbi.nlm.nih.gov/pubmed/36429060 http://dx.doi.org/10.3390/cells11223629 |
Ejemplares similares
-
Targeting calcium signaling in Alzheimer’s disease: challenges and promising therapeutic avenues
por: Song, LinLin, et al.
Publicado: (2023) -
Promising avenues of therapeutics for bipolar illness
por: Post, Robert M.
Publicado: (2008) -
Combination Therapy With Charged Particles and Molecular Targeting: A Promising Avenue to Overcome Radioresistance
por: Konings, Katrien, et al.
Publicado: (2020) -
Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression
por: Jain, Prateek, et al.
Publicado: (2023) -
48. TOPICAL CAPTOPRIL: A PROMISING THERAPEUTIC AVENUE FOR LYMPHEDEMA TREATMENT
por: Brown, Stav, et al.
Publicado: (2022)